These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30940121)

  • 1. Phenprocoumon based anticoagulation is an underestimated factor in the pathogenesis of calciphylaxis.
    Russ P; Russwurm M; Kortus-Goetze B; Hoyer J; Kamalanabhaiah S
    BMC Nephrol; 2019 Apr; 20(1):114. PubMed ID: 30940121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of Calciphylaxis: Cohort Study With Clinical Correlations.
    Chen TY; Lehman JS; Gibson LE; Lohse CM; El-Azhary RA
    Am J Dermatopathol; 2017 Nov; 39(11):795-802. PubMed ID: 29053546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K antagonists predispose to calciphylaxis in patients with end-stage renal disease.
    Galloway PA; El-Damanawi R; Bardsley V; Pritchard NR; Fry AC; Ojha SK; Hiemstra TF
    Nephron; 2015; 129(3):197-201. PubMed ID: 25720849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calciphylaxis-Associated Cutaneous Vascular Calcification in Noncalciphylaxis Patients.
    Chaudet KM; Dutta P; Nigwekar SU; Nazarian RM
    Am J Dermatopathol; 2020 Aug; 42(8):557-563. PubMed ID: 32701689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciphylaxis.
    Nigwekar SU
    Curr Opin Nephrol Hypertens; 2017 Jul; 26(4):276-281. PubMed ID: 28375870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Australian Calciphylaxis Registry: reporting clinical features and outcomes of patients with calciphylaxis.
    Ruderman I; Toussaint ND; Hawley CM; Krishnasamy R; Pedagogos E; Lioufas N; Elder GJ
    Nephrol Dial Transplant; 2021 Mar; 36(4):649-656. PubMed ID: 31855262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calciphylaxis, risk factors, treatment and outcomes. Retrospective study of 39 patients].
    Torre AC; Bastard DP; Diehl M; Rosa-Diez G; Volonteri V; Mazzuoccolo LD; Belatti AL
    Medicina (B Aires); 2024; 84(2):196-205. PubMed ID: 38683504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous calciphylaxis: a retrospective histopathologic evaluation.
    Mochel MC; Arakaki RY; Wang G; Kroshinsky D; Hoang MP
    Am J Dermatopathol; 2013 Jul; 35(5):582-6. PubMed ID: 23328789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calciphylaxis.
    Zhou Q; Neubauer J; Kern JS; Grotz W; Walz G; Huber TB
    Lancet; 2014 Mar; 383(9922):1067. PubMed ID: 24582472
    [No Abstract]   [Full Text] [Related]  

  • 10. Calciphylaxis: what nurses need to know.
    Bliss DE
    Nephrol Nurs J; 2002 Oct; 29(5):433-8, 443-4; quiz 445-6. PubMed ID: 12434450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
    Yousuf S; Busch D; Renner R; Schliep S; Erfurt-Berge C
    Ren Fail; 2024 Dec; 46(1):2297566. PubMed ID: 38178572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study of calciphylaxis in Japanese end-stage renal disease patients.
    Hayashi M; Takamatsu I; Kanno Y; Yoshida T; Abe T; Sato Y;
    Nephrol Dial Transplant; 2012 Apr; 27(4):1580-4. PubMed ID: 22121234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease].
    Verdalles Guzmán U; de la Cueva P; Verde E; García de Vinuesa S; Goicoechea M; Mosse A; López Gómez JM; Luño J
    Nefrologia; 2008; 28(1):32-6. PubMed ID: 18336128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy.
    Hafner J; Keusch G; Wahl C; Sauter B; Hürlimann A; von Weizsäcker F; Krayenbühl M; Biedermann K; Brunner U; Helfenstein U
    J Am Acad Dermatol; 1995 Dec; 33(6):954-62. PubMed ID: 7490365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis.
    Au S; Crawford RI
    J Am Acad Dermatol; 2002 Jul; 47(1):53-7. PubMed ID: 12077581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciphylaxis: Diagnosis, Pathogenesis, and Treatment.
    Chang JJ
    Adv Skin Wound Care; 2019 May; 32(5):205-215. PubMed ID: 31008757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calciphylaxis: a rare limb and life threatening cause of ischaemic skin necrosis and ulceration.
    Edwards RB; Jaffe W; Arrowsmith J; Henderson HP
    Br J Plast Surg; 2000 Apr; 53(3):253-5. PubMed ID: 10738337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: update on the management of calciphylaxis.
    Seethapathy H; Brandenburg VM; Sinha S; El-Azhary RA; Nigwekar SU
    QJM; 2019 Jan; 112(1):29-34. PubMed ID: 30304522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Hypercoagulable Conditions and Calciphylaxis in Patients With Renal Disease: A Case-Control Study.
    Dobry AS; Ko LN; St John J; Sloan JM; Nigwekar S; Kroshinsky D
    JAMA Dermatol; 2018 Feb; 154(2):182-187. PubMed ID: 29238798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual case of calciphylaxis.
    Kouba DJ; Owens NM; Barrett TL; Laman SD
    J Cutan Med Surg; 2004; 8(1):19-22. PubMed ID: 14735394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.